We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$99.2B
AUM Growth
+$5.03B
(+5.3%)
Cap. Flow
-$3.09B
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
3,988
New
43
Increased
2,065
Reduced
941
Closed
658
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$283M |
| 2 |
Microsoft
MSFT
|
+$139M |
| 3 |
UBS Group
UBS
|
+$131M |
| 4 |
Mercado Libre
MELI
|
+$96.4M |
| 5 |
Alcon
ALC
|
+$66.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$309M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$230M |
| 3 |
Apple
AAPL
|
+$226M |
| 4 |
Alibaba
BABA
|
+$225M |
| 5 |
Morgan Stanley
MS
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.84% |
| 2 | Healthcare | 15.57% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Codexis
CDXS
$157M
| $200K | ﹤0.01% |
48,424
+16
| +0% | +$84 |
|
|
ZYXI
3002
DELISTED
Zynex
ZYXI
| $199K | ﹤0.01% |
16,595
+16,591
| +414,775% | +$217K |
|
3003
Ramaco Resources Class A
METC
$647M
| $198K | ﹤0.01% |
23,287
+6
| +0% | +$56 |
|
|
GOEV
3004
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $197K | ﹤0.01% |
655
+239
| +57% | +$101K |
|
3005
Donegal Group Class A
DGICA
$716M
| $196K | ﹤0.01% |
12,840
+3,903
| +44% | +$58.7K |
|
3006
Tarsus Pharmaceuticals
TARS
$2.81B
| $196K | ﹤0.01% |
15,553
+2,118
| +16% | +$31K |
|
3007
abrdn Physical Gold Shares ETF
SGOL
$7.41B
| $194K | ﹤0.01% |
10,284
| – | – |
|
3008
Gilat Satellite Networks
GILT
$846M
| $192K | ﹤0.01% |
37,452
-127
| -0.3% | -$722 |
|
3009
SES AI
SES
$197M
| $191K | ﹤0.01% |
64,750
+32
| +0% | +$101 |
|
3010
Compass Therapeutics
CMPX
$384M
| $190K | ﹤0.01% |
+58,159
| New | +$228K |
|
3011
MiMedx Group
MDXG
$625M
| $190K | ﹤0.01% |
55,591
+7,112
| +15% | +$27.5K |
|
3012
Bridgewater Bancshares
BWB
$600M
| $188K | ﹤0.01% |
17,311
+2,214
| +15% | +$32.5K |
|
3013
Rimini Street
RMNI
$467M
| $187K | ﹤0.01% |
45,450
+14
| +0% | +$63 |
|
|
NGMS
3014
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $183K | ﹤0.01% |
12,061
-47
| -0.4% | -$661 |
|
|
AMPS
3015
DELISTED
Altus Power
AMPS
| $183K | ﹤0.01% |
33,335
+12
| +0% | +$84 |
|
|
FIRY
3016
Firy Inc
FIRY
$157M
| $183K | ﹤0.01% |
15,384
-9,625
| -38% | -$128K |
|
3017
Cellebrite
CLBT
$3.92B
| $182K | ﹤0.01% |
29,948
-11,581
| -28% | -$62.8K |
|
3018
Vuzix
VUZI
$222M
| $181K | ﹤0.01% |
43,750
+16
| +0% | +$72 |
|
3019
Prime Medicine
PRME
$544M
| $181K | ﹤0.01% |
14,705
+13,905
| +1,738% | +$227K |
|
3020
Entrada Therapeutics
TRDA
$264M
| $180K | ﹤0.01% |
12,399
+3,588
| +41% | +$47.9K |
|
3021
Organogenesis Holdings
ORGO
$219M
| $179K | ﹤0.01% |
84,248
+15
| +0% | +$37 |
|
3022
AerSale
ASLE
$274M
| $179K | ﹤0.01% |
10,377
+4
| +0% | +$71 |
|
|
TDCX
3023
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $179K | ﹤0.01% |
20,061
-66
| -0.3% | -$797 |
|
|
OTLY
3024
Oatly Group
OTLY
$439M
| $177K | ﹤0.01% |
3,653
-2,621
| -42% | -$122K |
|
3025
HUTCHMED
HCM
$2.15B
| $176K | ﹤0.01% |
13,548
| – | – |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2023 Portfolio in Review
As of Q1 2023, Credit Suisse held 3,988 positions worth $99.2B, up 5.3% from $94.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Credit Suisse withdrew a net $3.09B in Q1 2023, closing 658 positions and reducing 941 holdings. Its most notable exit was Cresud SACIF y A. Warrant, an estimated $59.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in GE HealthCare worth $34.2M.
- Credit Suisse's largest Q1 2023 buy was GE HealthCare: 417,250 shares worth $34.2M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $283M increase.
- Credit Suisse's biggest Q1 2023 reduction was Amazon, cutting an estimated $309M.
- Credit Suisse fully exited Cresud SACIF y A. Warrant in Q1 2023, selling an estimated $59.2M.
- Credit Suisse's ten largest holdings make up 20% of its $99.2B portfolio in Q1 2023.
- Credit Suisse opened 43 new positions and closed 658 in Q1 2023.
- Credit Suisse's portfolio value rose 5.3% quarter-over-quarter to $99.2B.
Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.